Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
130.59
+1.33 (+1.03%)
Official Closing Price
Updated: 7:00 PM EST, Nov 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
50
51
Next >
Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit
↗
January 22, 2025
The company expects to earn an adjusted $5.05 to $5.25 per share this year, in line with forecasts for $5.16.
Via
Investor's Business Daily
US Stocks Likely To Open Higher As President Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch
↗
January 22, 2025
U.S. stocks could open on a positive note on Wednesday, continuing to rally after Donald Trump's inauguration as the 47th President of the U.S. on Monday.
Via
Benzinga
Topics
Artificial Intelligence
Government
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
↗
January 22, 2025
The CNN Business Fear & Greed Index measures market sentiment, with higher fear putting pressure on stocks.
Via
Benzinga
Topics
Government
Stocks
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday
↗
January 22, 2025
Via
Benzinga
How Is The Market Feeling About Abbott Laboratories?
↗
December 30, 2024
Via
Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
↗
December 06, 2024
Via
Benzinga
ABBOTT LABORATORIES (NYSE:ABT) Technical Analysis observations.
↗
December 02, 2024
Will ABBOTT LABORATORIES breakout?
Via
Chartmill
Earnings Scheduled For January 22, 2025
↗
January 22, 2025
Via
Benzinga
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
↗
January 21, 2025
Via
The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
↗
January 21, 2025
Via
The Motley Fool
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
↗
January 21, 2025
Via
The Motley Fool
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
↗
January 15, 2025
The U.S. Food and Drug Administration announced a ban on Red No. 3, an artificial food coloring linked to cancer in animal studies, effective Jan. 15, 2027.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 14, 2025
Via
Benzinga
3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees
↗
January 14, 2025
Via
The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
↗
January 08, 2025
Via
Benzinga
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
↗
January 07, 2025
Barclays analyst initiates Positive coverage on Anteris Technologies, forecasting a 4%-5% U.S. TAVR market share for DurAVR by 2030.
Via
Benzinga
2 No-Brainer Dividend Stocks to Buy With $250 in 2025
↗
January 06, 2025
Via
The Motley Fool
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
↗
January 04, 2025
Via
The Motley Fool
3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years
↗
January 02, 2025
Via
The Motley Fool
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
↗
December 28, 2024
Via
The Motley Fool
10 Dividend Stocks For Intergenerational Wealth
↗
December 27, 2024
The Dividend Aristocrats broadly have durable competitive advantages, and long-term growth.
Via
Talk Markets
Topics
Stocks / Equities
Introducing the "Dividend Seven" Stocks
↗
December 24, 2024
Via
The Motley Fool
My Top 10 Stocks to Buy for 2025
↗
December 21, 2024
Via
The Motley Fool
2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond
↗
December 19, 2024
Via
The Motley Fool
The Smartest Dividend Stocks to Buy With $500 Right Now
↗
December 18, 2024
Via
The Motley Fool
Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them
↗
December 11, 2024
Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and Archer Aviation.
Via
Benzinga
“Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances”
December 06, 2024
Via
AB Newswire
2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
↗
November 26, 2024
Via
The Motley Fool
ABBOTT LABORATORIES (NYSE:ABT) Reveals Intriguing Technical Aspects. Here's What You Need to Know.
↗
November 25, 2024
Exploring ABBOTT LABORATORIES's Technical Signals and Breakout Potential.
Via
Chartmill
2 Dividend Kings to Buy for a Lifetime of Passive Income
↗
November 22, 2024
Via
The Motley Fool
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
50
51
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today